Form 4 holding
Interim CEO & General Counsel, Director
IOVANCE BIOTHERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 553,505
- Estimated value
- $1,942,802
- Report date
- 01 Jun 2026
- Price
- $3.51
- Ownership
- Direct